Rituximab as an Adjuvant Therapy for Pemphigus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Rituximab as an Adjuvant Therapy for Pemphigus: Experience in 61 Patients From a Single Center With Long-Term Follow-Up
Int. J. Dermatol 2019 Jun 30;[EPub Ahead of Print], VK Sharma, V Gupta, N Bhari, V SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.